Browse 1,572 kidney cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
Many kidney cancers are now found by chance, on a scan done for another reason, often while they are still small and curable with surgery. About 9 in 10 are renal cell carcinoma. For advanced kidney cancer, combinations of immunotherapy and targeted drugs have transformed outcomes over the past decade. Trials are testing what comes next when these combinations stop working, and whether extra treatment after surgery can keep the cancer from returning.
Location: Silver Spring MD, Detroit MI, Houston TX, Dallas TX
Sponsor: Bio-Path Holdings, Inc.
Sex: All
Age: 18+
Code: NCT04196257
Phase 1, Recruiting
A First-in-human (FIH), Phase I Study of PTX-912 in Patients with Locally Advanced/Metastatic Solid Tumors
for
Advanced Cancer, Solid Tumor, Metastatic Cancer
Location: Miami FL, Omaha NE, Duarte CA
Sponsor: Proviva Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06190886
Phase 1, Recruiting
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
for
Metastatic Colorectal Carcinoma,
Location: The Bronx NY, New York NY, Pittsburgh PA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05803382
Phase 1, Recruiting
Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors
for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT04771520
Phase 2, Recruiting
Cancer Genetic Testing in Ethnic Populations
for
Breast Carcinoma, Carcinoma of Unknown Primary,
Location: Jacksonville FL, Scottsdale AZ
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT04475640
Recruiting
AnovaOS Network Powered Patient Registry
for
Infectious Disease, Neoplasms,
Location: Arlington Heights IL
Sponsor: Anova Enterprises, Inc
Sex: All
Age: 18+
Code: NCT05013944
Recruiting
Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors
for
Anatomic Stage III Breast Cancer AJCC v8,
Location: Boston MA, Pittsburgh PA, Houston TX, Newport Beach CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12+
Code: NCT05372640
Phase 1, Recruiting
Trial of DFP-14927 in Advanced Solid Tumors
for
Solid Tumor, Cancer
Location: Houston TX, Los Angeles CA
Sponsor: Delta-Fly Pharma, Inc.
Sex: All
Age: 18+
Code: NCT03943004
Phase 1, Recruiting
Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors
for
Rectal Adenocarcinoma, Clinical Stage: Stage II (T3-4, N-),
Location: Hartford CT, Commack NY, Uniondale NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT04165772
Phase 2, Recruiting
Provider-Mediated Communication of Genetic Testing Results to At-Risk Relatives of Cancer Patients to Improve Genetic Counseling and Testing Rates, Family HOPE Study
for
Hematopoietic and Lymphoid System Neoplasm,
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT05772130
Recruiting
MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
for
Solid Tumor, Advanced Cancer, Metastatic Cancer,
Location: Tampa FL
Sponsor: Memgen, Inc.
Sex: All
Age: 18+
Code: NCT05076760
Phase 1, Recruiting
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
for
Breast Carcinoma, Esophageal Carcinoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT00991094
Recruiting
Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors
for
Malignant Solid Tumors, Other Neoplasms Solid Tumors,
Location: Bethesda MD, Houston TX, Portland OR
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0+
Code: NCT03739827
Recruiting
Imaging Study of [89Zr]DFO-YS5 for Cancer Detection